TY  - GEN
AU  - Miyoshi,Seigo
AU  - Hamada,Hironobu
AU  - Hamaguchi,Naohiko
AU  - Kato,Aki
AU  - Katayama,Hitoshi
AU  - Irifune,Kazunori
AU  - Ito,Ryoji
AU  - Miyazaki,Tatsuhiko
AU  - Okura,Takafumi
AU  - Higaki,Jitsuo
TI  - Antitumor activity of MEK and PI3K inhibitors against malignant pleural             mesothelioma cells in vitro and in vivo
SN  - 1791-2423
PY  - 2012///1019
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Butadienes
KW  - Cell Proliferation
KW  - Chromones
KW  - Drug Synergism
KW  - G1 Phase Cell Cycle Checkpoints
KW  - Humans
KW  - MAP Kinase Kinase Kinases
KW  - antagonists & inhibitors
KW  - MAP Kinase Signaling System
KW  - Male
KW  - Mesothelioma
KW  - drug therapy
KW  - Mice
KW  - Mice, SCID
KW  - Morpholines
KW  - Nitriles
KW  - Phosphatidylinositol 3-Kinases
KW  - metabolism
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Pleural Neoplasms
KW  - Tumor Burden
KW  - Tumor Cells, Cultured
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.3892/ijo.2012.1462
ER  -